AbbVie (ABBV) Dividend Coverage Ratio (2013 - 2026)
AbbVie's (ABBV) quarterly Dividend Coverage Ratio came in at 1.18 in Q2 2026, up 264.24% year-over-year from 0.32 in Q2 2025, and up 421.5% quarter-over-quarter from 0.23 in Q1 2026.
Analysis
AbbVie (ABBV) Dividend Coverage Ratio (2013 - 2026) Analysis & Trends
AbbVie (ABBV) has reported Dividend Coverage Ratio for 14 consecutive years, with 1.18 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Dividend Coverage Ratio rose 264.24% year-over-year to 1.18 in Q2 2026; TTM through Jun 2026 was 0.53, a 58.54% increase from a year earlier, with the FY2025 full-year figure at 0.36, down 6.59% from the prior year.
- Dividend Coverage Ratio was 1.18 for Q2 2026 at AbbVie, up from 0.23 in the prior quarter.
- Over five years, Dividend Coverage Ratio peaked at 1.78 in Q1 2022 and troughed at 0.04 in Q1 2023.
- A 5-year average of 0.6 and a median of 0.5 in 2024 frame the typical range for Dividend Coverage Ratio.
- Across the five-year window, Dividend Coverage Ratio slumped 102.66% in 2024 and jumped 7560.28% in 2025, its largest moves.
- Over 5 years, Dividend Coverage Ratio stood at 0.99 in 2022, then tumbled by 68.19% to 0.31 in 2023, then tumbled by 102.66% to 0.01 in 2024, then jumped by 7560.28% to 0.62 in 2025, then surged by 88.91% to 1.18 in 2026.
- The last three Dividend Coverage Ratio figures came in at 1.18 (Q2 2026), 0.23 (Q1 2026), and 0.62 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 648.02 Bn | 627.27 Bn | 17.26 Bn | 1.71 |
| 2 | AbbVie | 442.19 Bn | 435.62 Bn | 12.70 Bn | 1.18 |
| 3 | Merck | 364.99 Bn | 357.85 Bn | 12.21 Bn | -0.62 |
| 4 | Novartis Ag | 267.21 Bn | 259.52 Bn | 11.24 Bn | 1.14 |
| 5 | Pfizer | 158.83 Bn | 147.13 Bn | 10.94 Bn | -0.10 |
| 6 | Sanofi | 52.58 Bn | 45.20 Bn | 10.79 Bn | 0.07 |
| 7 | Revolution Medicines | 44.25 Bn | 44.25 Bn | - | - |
| 8 | Incyte | 25.33 Bn | 20.80 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.28 Bn | 18.62 Bn | 683.80 Mn | - |
| 10 | Neurocrine Biosciences | 15.52 Bn | 15.13 Bn | 935.80 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.18 |
| Mar 31, 2026 | 0.23 |
| Dec 31, 2025 | 0.62 |
| Sep 30, 2025 | 0.06 |
| Jun 30, 2025 | 0.32 |
| Mar 31, 2025 | 0.44 |
| Dec 31, 2024 | -0.01 |
| Sep 30, 2024 | 0.57 |
| Jun 30, 2024 | 0.50 |
| Mar 31, 2024 | 0.49 |
| Dec 31, 2023 | 0.31 |
| Sep 30, 2023 | 0.68 |
| Jun 30, 2023 | 0.77 |
| Mar 31, 2023 | -0.04 |
| Dec 31, 2022 | 0.99 |
| Sep 30, 2022 | 1.58 |
| Jun 30, 2022 | 0.37 |
| Mar 31, 2022 | 1.78 |
| Dec 31, 2021 | 1.75 |
| Sep 30, 2021 | 1.37 |